Tau accumulation and its spatial progression across the Alzheimer’s disease spectrum
Abstract
The spread of tau abnormality in sporadic Alzheimer’s disease is believed typically to follow neuropathologically defined Braak staging. Recentin-vivopositron emission tomography (PET) evidence challenges this belief, however, as spreading patterns for tau appear heterogenous among individuals with varying clinical expression of Alzheimer’s disease. We therefore sought better understanding of the spatial distribution of tau in the preclinical and clinical phases of sporadic Alzheimer’s disease and its association with cognitive decline.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 05, 2023
- Source ID
- 10.1101/2023.06.02.23290880
Entities
People
- Alexa Pichet Binette
- Frédéric St‐Onge
- John Cs Breitner
- Marianne Chapleau
- Sylvia Villeneuve
- The Alzheimer’s Disease Neuroimaging Initiative*